Drug profile · INN
orlistat
ALLI (PREVIOUSLY ORLISTAT GSK)
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
orlistat (ALLI (PREVIOUSLY ORLISTAT GSK)) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12384854
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
granted -
US 12378245
Crystalline forms of an RSK inhibitor
granted -
US 12344585
Crystalline salts of a plasma kallikrein inhibitor
granted -
US 12338249
Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N′-methoxyurea
granted -
US 12329805
Dosage forms of tissue kallikrein 1
granted -
US 12319657
Solid state crystalline forms of a selective potassium channel modulator
granted -
US 12319651
Crystalline forms and methods of producing crystalline forms of a compound
granted
Frequently asked questions
What is orlistat?
orlistat (ALLI (PREVIOUSLY ORLISTAT GSK)) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for orlistat?
ALLI (PREVIOUSLY ORLISTAT GSK) is a marketed brand name for orlistat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of orlistat?
orlistat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.